Zhong, W.-B.; Tsai, Y.-C.; Chin, L.-H.; Tseng, J.-H.; Tang, L.-W.; Horng, S.; Fan, Y.-C.; Hsu, S.-P.
A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model. Int. J. Mol. Sci. 2018, 19, 1834.
https://doi.org/10.3390/ijms19071834
AMA Style
Zhong W-B, Tsai Y-C, Chin L-H, Tseng J-H, Tang L-W, Horng S, Fan Y-C, Hsu S-P.
A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model. International Journal of Molecular Sciences. 2018; 19(7):1834.
https://doi.org/10.3390/ijms19071834
Chicago/Turabian Style
Zhong, Wen-Bin, Yuan-Chin Tsai, Li-Han Chin, Jen-Ho Tseng, Li-Wen Tang, Steve Horng, Yu-Ching Fan, and Sung-Po Hsu.
2018. "A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model" International Journal of Molecular Sciences 19, no. 7: 1834.
https://doi.org/10.3390/ijms19071834
APA Style
Zhong, W. -B., Tsai, Y. -C., Chin, L. -H., Tseng, J. -H., Tang, L. -W., Horng, S., Fan, Y. -C., & Hsu, S. -P.
(2018). A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model. International Journal of Molecular Sciences, 19(7), 1834.
https://doi.org/10.3390/ijms19071834